You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • 'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies

 

Online download statistics by month:

Online download statistics by month: February 2021 to July 2025

AbstractFullPdf
Feb 2021446446306
Mar 2021277276187
Apr 202116516576
May 202115115155
Jun 202117117247
Jul 202114514530
Aug 202115315345
Sep 2021999931
Oct 202115715748
Nov 202112512554
Dec 2021858536
Jan 2022737438
Feb 2022838847
Mar 202211111648
Apr 202213414641
May 202212312744
Jun 202212413342
Jul 20229310337
Aug 202210711123
Sep 202211211940
Oct 202213213650
Nov 202211612031
Dec 202212813031
Jan 202316316653
Feb 202317818040
Mar 202311611840
Apr 20239910233
May 202314514753
Jun 202313013427
Jul 202313713723
Aug 202310610629
Sep 2023848816
Oct 20239310023
Nov 202314614741
Dec 202317717718
Jan 2024343912
Feb 2024969627
Mar 20248888116
Apr 2024989824
May 2024727321
Jun 2024717435
Jul 2024909526
Aug 2024697065
Sep 20243535145
Oct 2024838336
Nov 2024757627
Dec 202412714324
Jan 2025828937
Feb 2025616125
Mar 202510010152
Apr 2025969651
May 2025758028
Jun 2025313333
Jul 2025110
Total626864102567